GlassScriptPhysician profile
Brad Robin Baack
NPI 1104856061
$1,207.07
in general payments reported to CMS, 2019-2025
17 companies · $827 in 2025
The $827 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.97 · 2020: $19.17 · 2021: $14.69 · 2022: $17.15 · 2023: $52.77 · 2024: $229 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vaporox, INC. | $220.35 | 2025 | Vht-200 Wound Treatment System |
| Abbvie INC. | $181.62 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $171.40 | 2024-2025 | |
| Janssen Biotech, INC. | $107.48 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $86.29 | 2021-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $78.06 | 2025 | Sotyktu |
| Genzyme Corporation | $55.59 | 2025 | |
| Pfizer INC. | $48.69 | 2022-2023 | |
| Amgen INC. | $48.11 | 2025 | Otezla |
| Journey Medical Corporation | $40.48 | 2024-2025 | |
| Mimedx Group, INC. | $35.46 | 2025 | |
| Organon LLC | $30.60 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $24.08 | 2024 | |
| Incyte Corporation | $21.32 | 2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $21.23 | 2023 | Winlevi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18.72 | 2025 | Ebglyss |
| Dermavant Sciences, INC. | $17.59 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Baack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.